![Cells | Free Full-Text | Small Molecule Inhibitors in the Treatment of Rheumatoid Arthritis and Beyond: Latest Updates and Potential Strategy for Fighting COVID-19 Cells | Free Full-Text | Small Molecule Inhibitors in the Treatment of Rheumatoid Arthritis and Beyond: Latest Updates and Potential Strategy for Fighting COVID-19](https://www.mdpi.com/cells/cells-09-01876/article_deploy/html/images/cells-09-01876-g001.png)
Cells | Free Full-Text | Small Molecule Inhibitors in the Treatment of Rheumatoid Arthritis and Beyond: Latest Updates and Potential Strategy for Fighting COVID-19
![Comparing Small Molecules and Biologics | Clinical Practice Snapshot: Incorporating Janus Kinase Inhibitors Into the Management of Rheumatoid Arthritis | Global Academy for Medical Education Comparing Small Molecules and Biologics | Clinical Practice Snapshot: Incorporating Janus Kinase Inhibitors Into the Management of Rheumatoid Arthritis | Global Academy for Medical Education](https://www.globalacademycme.com/sites/default/files/clinical_practice_snapshot_art3_table1.png)
Comparing Small Molecules and Biologics | Clinical Practice Snapshot: Incorporating Janus Kinase Inhibitors Into the Management of Rheumatoid Arthritis | Global Academy for Medical Education
![Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach | Nature Reviews Rheumatology Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach | Nature Reviews Rheumatology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41584-021-00726-8/MediaObjects/41584_2021_726_Fig2_HTML.png)
Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach | Nature Reviews Rheumatology
Rheumatoid arthritis | JAK inhibitors: The next generation of drugs for treating rheumatoid arthritis? | rheumatology.medicinematters.com
![A Review on the Safety of Using JAK Inhibitors in Dermatology: Clinical and Laboratory Monitoring | SpringerLink A Review on the Safety of Using JAK Inhibitors in Dermatology: Clinical and Laboratory Monitoring | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13555-023-00892-5/MediaObjects/13555_2023_892_Fig1_HTML.png)
A Review on the Safety of Using JAK Inhibitors in Dermatology: Clinical and Laboratory Monitoring | SpringerLink
![Tofacitinib and Other Kinase Inhibitors Offer New Approach to Treating Rheumatoid Arthritis - Page 3 of 4 - The Rheumatologist Tofacitinib and Other Kinase Inhibitors Offer New Approach to Treating Rheumatoid Arthritis - Page 3 of 4 - The Rheumatologist](https://www.the-rheumatologist.org/wp-content/uploads/springboard/image/RHU_2013_06_pp28_t01_LG.jpg)
Tofacitinib and Other Kinase Inhibitors Offer New Approach to Treating Rheumatoid Arthritis - Page 3 of 4 - The Rheumatologist
![A comparison of Janus kinase inhibitor safety in rheumatoid arthritis - Nash - 2021 - International Journal of Rheumatic Diseases - Wiley Online Library A comparison of Janus kinase inhibitor safety in rheumatoid arthritis - Nash - 2021 - International Journal of Rheumatic Diseases - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/707a49fa-f7cd-4720-a119-f5d1a44c2c18/apl14127-fig-0001-m.jpg)
A comparison of Janus kinase inhibitor safety in rheumatoid arthritis - Nash - 2021 - International Journal of Rheumatic Diseases - Wiley Online Library
![Phytochemicals targeting JAK/STAT pathway in the treatment of rheumatoid arthritis: Is there a future? - ScienceDirect Phytochemicals targeting JAK/STAT pathway in the treatment of rheumatoid arthritis: Is there a future? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006295222000235-ga1.jpg)
Phytochemicals targeting JAK/STAT pathway in the treatment of rheumatoid arthritis: Is there a future? - ScienceDirect
![Phytochemicals targeting JAK/STAT pathway in the treatment of rheumatoid arthritis: Is there a future? - ScienceDirect Phytochemicals targeting JAK/STAT pathway in the treatment of rheumatoid arthritis: Is there a future? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006295222000235-gr2.jpg)
Phytochemicals targeting JAK/STAT pathway in the treatment of rheumatoid arthritis: Is there a future? - ScienceDirect
![The JAK/STAT pathway in rheumatoid arthritis: Pathogenic or protective? - Ivashkiv - 2003 - Arthritis & Rheumatism - Wiley Online Library The JAK/STAT pathway in rheumatoid arthritis: Pathogenic or protective? - Ivashkiv - 2003 - Arthritis & Rheumatism - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/090fcc6a-0ca7-4ef1-879b-a57e487a6a7e/mfig001.jpg)
The JAK/STAT pathway in rheumatoid arthritis: Pathogenic or protective? - Ivashkiv - 2003 - Arthritis & Rheumatism - Wiley Online Library
![JAK-STAT inhibitors: Immersing therapeutic approach for management of rheumatoid arthritis - ScienceDirect JAK-STAT inhibitors: Immersing therapeutic approach for management of rheumatoid arthritis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1567576920311851-gr1.jpg)
JAK-STAT inhibitors: Immersing therapeutic approach for management of rheumatoid arthritis - ScienceDirect
![PDF] Recent progress and perspective in JAK inhibitors for rheumatoid arthritis: from bench to bedside. | Semantic Scholar PDF] Recent progress and perspective in JAK inhibitors for rheumatoid arthritis: from bench to bedside. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/845f77db3e8de4c43bbcb5a7c172cbcdcc27298a/3-Figure2-1.png)
PDF] Recent progress and perspective in JAK inhibitors for rheumatoid arthritis: from bench to bedside. | Semantic Scholar
A biopolymer-based and inflammation-responsive nanodrug for rheumatoid arthritis treatment via inhibiting JAK-STAT and JNK signalling pathways - Nanoscale (RSC Publishing)
![Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement | Annals of the Rheumatic Diseases Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/80/1/71/F1.large.jpg)
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement | Annals of the Rheumatic Diseases
![Jackie and Jill: Talking About JAK Inhibitors While Caring for RA Patients | Ontario Pharmacists Association Jackie and Jill: Talking About JAK Inhibitors While Caring for RA Patients | Ontario Pharmacists Association](https://opatoday.com/wp-content/uploads/2022/11/Jackie-and-Jill-Talking-about-JAK-inhibitors.jpg)